title: Effects of aging on the human ovary: the secretion of immunoreactive alpha-inhibin and progesterone.
abstract: OBJECTIVE
  To investigate the changes induced by age in the function and secretory pattern of the human ovary. Immunoreactive alpha-inhibin, E2, and P secretion in vivo and in vitro have been compared in two different populations.
  
  
  METHODS
  Prospective study. Women undergoing IVF-ET were divided into two groups according to age: group 1 (32.0 +/- 0.7 years; mean +/- SEM) and group 2 (40.3 +/- 0.3 years).
  
  
  METHODS
  In vitro fertilization program at the Instituto Valenciano de Infertilidad.
  
  
  METHODS
  A total of 33 infertile women with regular menses, undergoing IVF-ET.
  
  
  METHODS
  Follicle aspiration performed by transvaginal ultrasound. Four follicles per patient were aspirated in individual plastic tubes. Granulosa-luteal cells isolated with Percoll columns and cultured in vitro up to 4 days in the presence of hCG.
  
  
  METHODS
  In vitro fertilization parameters, serum levels of E2, immunoreactive alpha-inhibin, and P, as well as the secretion of immunoreactive alpha-inhibin and P by the cultured granulosa-luteal cells.
  
  
  RESULTS
  Serum immunoreactive alpha-inhibin levels the day of ovum pick-up were significantly lower in group 2 compared with group 1. Incubation of cells for 96 hours showed a significantly higher ability to accumulate immunoreactive alpha-inhibin in group 1 than 2. Human chorionic gonadotropin stimulated immunoreactive alpha-inhibin production after 96 hours. Cells from younger women displayed a significantly higher ability to secrete P than cells from older women. Human chorionic gonadotropin was able to significantly stimulate P production in group 1.
  
  
  CONCLUSIONS
  These results confirm previous observations showing a reduced production of immunoreactive alpha-inhibin and steroids of ovaries from older women and suggest that a reduced cellular function, rather than a decrease in the follicular population, is the main mechanism by which these changes are produced.
authors.affiliation: Instituto Valenciano de Infertilidad, Valencia University School of Medicine, Spain.
authors.forename: A
authors.initials: A
authors.lastname: Pellicer
authors.forename: M
authors.initials: M
authors.lastname: Marí
authors.forename: M J
authors.initials: MJ
authors.lastname: de los Santos
authors.forename: C
authors.initials: C
authors.lastname: Simón
authors.forename: J
authors.initials: J
authors.lastname: Remohí
authors.forename: J J
authors.initials: JJ
authors.lastname: Tarín
mesh_terms: D000328:Adult; D000375:Aging; D002478:Cells, Cultured; D006063:Chorionic Gonadotropin / Q000494:pharmacology; D004624:Embryo Transfer; D004958:Estradiol / Q000378:metabolism; D005260:Female; D005307:Fertilization in Vitro; D015571:Follicular Fluid / Q000378:metabolism; D006107:Granulosa Cells / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D007265:Inhibins / Q000378:metabolism*; D008184:Luteal Cells / Q000187:drug effects / Q000378:metabolism; D010053:Ovary / Q000187:drug effects / Q000378:metabolism*; D011374:Progesterone / Q000378:metabolism*; D011446:Prospective Studies
chemical_list: D006063:Chorionic Gonadotropin; D011374:Progesterone; D004958:Estradiol; D007265:Inhibins